United States Cannabidiol (CBD) Market Overview

The United States cannabidiol (CBD) market is on an exceptionally robust growth trajectory, driven by surging consumer demand for natural wellness alternatives, the rapid evolution of the legal and regulatory landscape following the 2018 Farm Bill, and growing mainstream retail acceptance of CBD products. Valued at USD 2.2 Billion in 2024, the market is projected to reach USD 20.3 Billion by 2033, exhibiting a remarkable CAGR of 27.8% during 2025–2033. Growth is powered by increasing product diversification across oils, edibles, topicals, and pet care, rising pharmaceutical interest in cannabidiol formulations, and expanding B2C distribution through major retail chains and e-commerce platforms.

Access In-Depth Market Intelligence — Download Your Free Sample Copy: https://www.imarcgroup.com/united-states-cannabidiol-market/requestsample

Key Market Statistics at a Glance

  • Base Year: 2024
  • Historical Years: 2019–2024
  • Forecast Period: 2025–2033
  • Market Size (2024): USD 2.2 Billion
  • Projected Size (2033): USD 20.3 Billion
  • Growth Rate: CAGR of 27.8%

United States Cannabidiol Market Growth Trends

• Growing Consumer Awareness and Demand for Natural Wellness Products The increasing consumer awareness of CBD's potential health and wellness benefits is one of the most powerful drivers of market growth. As consumers actively seek natural alternatives to traditional pharmaceuticals, CBD has gained widespread popularity for its reported ability to alleviate anxiety, reduce inflammation, and manage chronic pain. The broader wellness movement toward plant-based and organic products is further aligning consumer preferences with CBD adoption across oils, tinctures, capsules, and edibles.

• Supportive Legal and Regulatory Developments The legal and regulatory framework in the United States has been a transformative catalyst for the CBD market. The 2018 Farm Bill removed hemp-derived CBD from the Controlled Substances Act, legitimizing its use in wellness and dietary supplement applications and opening the door for widespread industry investment. Subsequent state-level regulatory frameworks clarifying production, distribution, and sales standards have reinforced business confidence, stimulated innovation, and expanded the availability of CBD products across the country.

• Increased Product Diversification Companies are rapidly diversifying their CBD product portfolios to cater to evolving consumer preferences and health needs. From CBD-infused sparkling waters and protein bars to functional gummies, topical creams, and sleep aids, the breadth of available formats continues to expand. This diversification not only widens the consumer base but enables brands to differentiate themselves in an increasingly competitive environment, driving robust volume growth across both established and emerging product categories.

• Expansion of CBD in Pet Care Products The pet care segment has emerged as one of the fastest-growing application areas in the U.S. CBD market, fueled by growing pet owner awareness of natural remedies for anxiety, joint pain, and mobility issues in animals. CBD-infused oils, treats, capsules, and chews targeting specific pet health concerns are gaining strong consumer traction, reflecting a broader holistic approach to animal wellness that mirrors trends in human health and wellness consumption.

• Growing Acceptance in Mainstream Retail The mainstream retail expansion of CBD products is significantly amplifying market reach and consumer accessibility. Major national retail chains — including Walgreens, CVS, Kroger, and Walmart — have materially increased their CBD product assortments, normalizing their usage and fostering far greater market penetration than niche specialty stores alone could achieve. This shift signals increasing consumer confidence and regulatory clarity, driving substantial incremental demand across the country.

Get Customized Segmentation Intelligence — Speak Directly to Our Expert: https://www.imarcgroup.com/request?type=report&id=19956&flag=C

United States Cannabidiol Industry Segmentation

IMARC Group provides detailed segmentation analysis across product, source type, grade, and sales type categories, with forecasts at regional and country levels for 2025–2033.

Analysis by Product

  • CBD Oil — Leading Segment CBD oil is the dominant product in the U.S. cannabidiol market, valued for its versatility across wellness, pain management, and anxiety relief applications. Its wide integration into pharmaceutical, dietary supplement, and personal care product formulations continues to drive strong consumer adoption and volume leadership within the market.
  • CBD Isolates CBD isolates, offering 99% or higher CBD concentration with no other cannabinoids or terpenes, serve consumers specifically seeking THC-free solutions. Their precision and purity make them a preferred ingredient for manufacturers developing advanced wellness products, cosmetics, and pharmaceutical formulations requiring exact dosing standards.
  • CBD Concentrates CBD concentrates are highly potent extracts that cater to consumers seeking strong therapeutic benefits and to manufacturers requiring concentrated raw material for premium product formulations. Their role in producing advanced wellness, pharmaceutical, and cosmetic products is driving ongoing innovation and adoption across multiple end-use sectors.
  • Others This includes CBD-infused edibles, beverages, topicals, and pet products, representing a growing and diverse array of consumer-facing applications that collectively account for a meaningful and expanding share of total market volume.

Analysis by Source Type

  • Hemp — Primary Source Hemp is the cornerstone source type for the U.S. CBD market, providing extracts with minimal THC content that comply with federal regulations. Hemp-derived CBD serves as the primary raw material for oils, isolates, edibles, and cosmetics, catering to the dominant consumer preference for non-psychoactive CBD products.
  • Marijuana Marijuana-derived CBD, which contains higher THC concentrations, serves medical and certain recreational applications. It is particularly relevant for patients requiring potent therapeutic effects in the management of chronic pain, epilepsy, and anxiety-related conditions, and supports premium CBD product innovation in states with permissive regulatory frameworks.

Analysis by Grade

  • Food Grade Food-grade cannabidiol adheres to strict safety and quality standards required for consumption in edibles, beverages, and dietary supplements. This grade ensures regulatory compliance and meets consumer demand for safe, high-quality CBD-infused food and wellness products, making it a critically important category as mainstream food and beverage applications expand.
  • Therapeutic Grade Therapeutic-grade CBD is specifically formulated for medical and clinical wellness applications, ensuring high purity and potency for treating conditions including chronic pain, anxiety, and inflammation. This grade supports pharmaceutical innovation and clinical research and is increasingly sought by both healthcare providers and consumers prioritizing efficacy and quality.

Analysis by Sales Type

  • B2B B2B sales facilitate bulk CBD distribution across manufacturers, wholesalers, and retailers, streamlining the supply chain and enabling large-scale production. This segment supports efficient raw material sourcing, underpins strategic commercial partnerships, and plays a foundational role in sustaining market growth at the manufacturing and distribution tiers.
  • B2C B2C sales — encompassing direct-to-consumer transactions through retail outlets, e-commerce platforms, and brand-owned stores — are growing rapidly as digital channels and mainstream retail accessibility make CBD products more available than ever before. This segment fosters personalized consumer engagement, drives brand loyalty, and enables brands to build direct relationships with an expanding wellness-oriented customer base.

Regional Spotlight: Where Is Growth Concentrated?

West — Innovation and Market Leadership The West, particularly California and Colorado, leads the U.S. CBD market through advanced hemp cultivation practices, a progressive regulatory environment, and the highest concentration of leading CBD manufacturers and innovative product developers. Strong consumer demand for wellness products, early adoption culture, and a robust supply chain infrastructure position this region as a premier growth hub.

South — Agricultural Powerhouse and Growing Consumer Market The South plays a crucial role in the U.S. CBD market through extensive hemp farming, favorable climate conditions, and progressively supportive state-level legislation. Its robust agricultural infrastructure and rapidly growing consumer base are driving production, distribution, and market expansion, establishing the South as a key contributor to the national CBD supply chain and consumer market.

Northeast — Progressive Regulatory Environment and Strong Urban Demand The Northeast benefits from a progressive regulatory environment, a large and health-conscious urban consumer base, and strong retail networks. Cities such as New York and Boston generate significant B2C demand for premium CBD wellness products, while the region's concentration of research institutions and pharmaceutical companies supports ongoing product development and clinical exploration of CBD applications.

Midwest — Key Production Hub and Expanding Consumer Adoption The Midwest contributes significantly to the CBD market through expanding hemp cultivation, favorable agricultural resources, and supportive regulatory developments. The region serves as an important production and supply chain hub, while growing consumer awareness and increasing retail distribution are driving steadily rising demand for high-quality CBD products across both urban and suburban markets.

Future Scope: What Lies Ahead for the U.S. Cannabidiol Market?

• FDA Regulatory Clarity and Market Formalization The anticipated finalization of comprehensive FDA guidelines covering CBD's use in foods, beverages, and dietary supplements will be a pivotal development for the market. Clearer federal standards will reduce regulatory uncertainty, encourage new market entrants, facilitate increased investment, and accelerate adoption of CBD across mainstream consumer product categories.

• Pharmaceutical and Clinical Expansion Growing pharmaceutical interest in CBD-based therapeutics — driven by the success of approved CBD medications and the continued accumulation of clinical evidence supporting cannabidiol's therapeutic efficacy — is expected to fuel substantial investment in drug development, clinical trials, and medical applications. This will elevate the market's credibility and open significant new revenue streams for high-purity, therapeutic-grade CBD.

• Innovation in Delivery Formats and Bioavailability Advances in nano-emulsification, water-soluble CBD technology, and novel delivery mechanisms are expected to significantly improve bioavailability and enhance the effectiveness of CBD products. These innovations will drive new product launches across beverages, fast-acting edibles, and transdermal applications, expanding the appeal of CBD to a broader and more diverse consumer audience.

• Expansion of CBD in Beauty and Personal Care The beauty and personal care industry is emerging as a major growth frontier for CBD, with brands incorporating cannabidiol into skincare, haircare, and anti-aging formulations for its reported anti-inflammatory and antioxidant properties. As consumer acceptance of CBD-infused cosmetics grows, this segment is expected to contribute meaningfully to overall market expansion throughout the forecast period.

• Growth of E-Commerce and Direct-to-Consumer Channels The continued expansion of e-commerce platforms and brand-owned digital storefronts will play a central role in driving B2C market growth, enabling CBD brands to reach consumers beyond the geographic limitations of physical retail, personalize the customer experience, and build sustained brand loyalty in an increasingly competitive marketplace.

Frequently Asked Questions (FAQ)

1.What is cannabidiol (CBD)?

Cannabidiol (CBD) is a non-intoxicating compound derived from the cannabis plant, known for its potential therapeutic benefits. It interacts with the body's endocannabinoid system, helping to manage pain, inflammation, anxiety, and other conditions. CBD is widely used in wellness, pharmaceuticals, and cosmetics — commonly available in oils, edibles, topicals, and capsules.

2. How big is the United States cannabidiol market?

The U.S. cannabidiol market was valued at USD 2.2 Billion in 2024.

3. What is the projected value of the market by 2033?

The market is expected to reach USD 20.3 Billion by 2033, driven by expanding legalization, product diversification, pharmaceutical innovation, and growing mainstream consumer adoption.

4. What is the expected CAGR of the U.S. cannabidiol market?

The market is projected to grow at a CAGR of 27.8% during 2025–2033.

5. Which region dominates the U.S. cannabidiol market?

The West region, particularly California and Colorado, is a leading market, supported by advanced hemp cultivation, strong consumer demand, and a concentration of innovative CBD manufacturers and product developers.

6. What are the key growth drivers of the U.S. cannabidiol market?

Major growth drivers include increasing consumer awareness of CBD's wellness benefits, expanding legalization under the 2018 Farm Bill, rising product diversification, growing CBD adoption in pet care, mainstream retail expansion, and increasing pharmaceutical and clinical research investment in cannabidiol-based therapies.

About IMARC Group

IMARC Group is a leading global market research company providing data-driven insights and expert consulting services to businesses seeking to achieve their strategic objectives. With a multi-disciplinary team of industry experts, IMARC delivers thorough, reliable market intelligence across sectors including Chemicals and Materials, Healthcare, Technology, Agriculture, Retail, and more.

Contact

IMARC Group

Email: sales@imarcgroup.com

United States: +1–201–971–6302

India: +91–120–433–0800

United Kingdom: +44–753–714–6104